AP-1, NF-kappa-B, and ERK activation thresholds for promotion of neoplastic transformation in the mouse epidermal JB6 model (original) (raw)

Abstract

The promotion-sensitive mouse epidermal JB6 cells (clone 41) have been used to identify the tumor-promoting activity of various compounds. Because treatment by tumor promoters [12-O-tetradecanoylphorbol-13-acetate (TPA), epidermal growth factor (EGF), or tumor necrosis factor alpha (TNF-alpha)] transforms clone 41 cells to anchorage-independent and tumorigenic phenotypes, they are considered to be undergoing late-stage tumor promotion. Here we address the question of how much activation of transformation-relevant transcription factors [activator protein-1 (AP-1), ternary complex factors (TCFs), or nuclear factor kappa-B (NF-kappa-B)] is required for transformation response and how much tumor promoter produces significant risk of transformation. Stable transfectants harboring a reporter construct with an AP-1 response element, serum-response element (SRE), or NF-kappa-B response element were established. We examined the relationship between concentration of tumor promoters, key signaling events, and activation of the transcription factors. A concentration of > 0.2 nM TPA or 0.12 ng/mL (0.02 nM) EGF produced a significant increase in transformation response as well as in extracellular signal-regulated protein kinase (ERK), SRE, or AP-1 activation. Treatment with > 0.4 U/mL (2.35 pM) TNF-alpha increased NF-kappa-B activity and transformation response in a dose-dependent manner. However, transformation response decreased at > 33 U/mL TNF-alpha due to a cytotoxic response. These findings suggest that the signaling pathway leading to the activation of ERK, TCF, and AP-1 proteins constitutes a major factor determining the risk of tumor promotion by TPA or EGF. Cell toxicity in addition to NF-kappa-B activation should be considered in predicting TNF-alpha-induced transformation response.

Full Text

The Full Text of this article is available as a PDF (571.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Angel P., Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta. 1991 Dec 10;1072(2-3):129–157. doi: 10.1016/0304-419x(91)90011-9. [DOI] [PubMed] [Google Scholar]
  2. Ben-Ari E. T., Bernstein L. R., Colburn N. H. Differential c-jun expression in response to tumor promoters in JB6 cells sensitive or resistant to neoplastic transformation. Mol Carcinog. 1992;5(1):62–74. doi: 10.1002/mc.2940050111. [DOI] [PubMed] [Google Scholar]
  3. Bernstein L. R., Colburn N. H. AP1/jun function is differentially induced in promotion-sensitive and resistant JB6 cells. Science. 1989 May 5;244(4904):566–569. doi: 10.1126/science.2541502. [DOI] [PubMed] [Google Scholar]
  4. Bode A. M., Ma W. Y., Surh Y. J., Dong Z. Inhibition of epidermal growth factor-induced cell transformation and activator protein 1 activation by [6]-gingerol. Cancer Res. 2001 Feb 1;61(3):850–853. [PubMed] [Google Scholar]
  5. Cobb M. H., Hepler J. E., Cheng M., Robbins D. The mitogen-activated protein kinases, ERK1 and ERK2. Semin Cancer Biol. 1994 Aug;5(4):261–268. [PubMed] [Google Scholar]
  6. Colburn N. H., Former B. F., Nelson K. A., Yuspa S. H. Tumour promoter induces anchorage independence irreversibly. Nature. 1979 Oct 18;281(5732):589–591. doi: 10.1038/281589a0. [DOI] [PubMed] [Google Scholar]
  7. Dong Z., Birrer M. J., Watts R. G., Matrisian L. M., Colburn N. H. Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells. Proc Natl Acad Sci U S A. 1994 Jan 18;91(2):609–613. doi: 10.1073/pnas.91.2.609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dong Z., Huang C., Brown R. E., Ma W. Y. Inhibition of activator protein 1 activity and neoplastic transformation by aspirin. J Biol Chem. 1997 Apr 11;272(15):9962–9970. doi: 10.1074/jbc.272.15.9962. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Dong Z., Ma W., Huang C., Yang C. S. Inhibition of tumor promoter-induced activator protein 1 activation and cell transformation by tea polyphenols, (-)-epigallocatechin gallate, and theaflavins. Cancer Res. 1997 Oct 1;57(19):4414–4419. [PubMed] [Google Scholar]
  10. Gille H., Strahl T., Shaw P. E. Activation of ternary complex factor Elk-1 by stress-activated protein kinases. Curr Biol. 1995 Oct 1;5(10):1191–1200. doi: 10.1016/s0960-9822(95)00235-1. [DOI] [PubMed] [Google Scholar]
  11. Hsu T. C., Nair R., Tulsian P., Camalier C. E., Hegamyer G. A., Young M. R., Colburn N. H. Transformation nonresponsive cells owe their resistance to lack of p65/nuclear factor-kappaB activation. Cancer Res. 2001 May 15;61(10):4160–4168. [PubMed] [Google Scholar]
  12. Hsu T. C., Young M. R., Cmarik J., Colburn N. H. Activator protein 1 (AP-1)- and nuclear factor kappaB (NF-kappaB)-dependent transcriptional events in carcinogenesis. Free Radic Biol Med. 2000 May 1;28(9):1338–1348. doi: 10.1016/s0891-5849(00)00220-3. [DOI] [PubMed] [Google Scholar]
  13. Huang C., Ma W. Y., Dong Z. The extracellular-signal-regulated protein kinases (Erks) are required for UV-induced AP-1 activation in JB6 cells. Oncogene. 1999 May 6;18(18):2828–2835. doi: 10.1038/sj.onc.1202639. [DOI] [PubMed] [Google Scholar]
  14. Huang C., Ma W. Y., Li J., Goranson A., Dong Z. Requirement of Erk, but not JNK, for arsenite-induced cell transformation. J Biol Chem. 1999 May 21;274(21):14595–14601. doi: 10.1074/jbc.274.21.14595. [DOI] [PubMed] [Google Scholar]
  15. Huang C., Ma W. Y., Young M. R., Colburn N., Dong Z. Shortage of mitogen-activated protein kinase is responsible for resistance to AP-1 transactivation and transformation in mouse JB6 cells. Proc Natl Acad Sci U S A. 1998 Jan 6;95(1):156–161. doi: 10.1073/pnas.95.1.156. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Janknecht R., Hunter T. Convergence of MAP kinase pathways on the ternary complex factor Sap-1a. EMBO J. 1997 Apr 1;16(7):1620–1627. doi: 10.1093/emboj/16.7.1620. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Kitchin K. T., Brown J. L., Setzer R. W. Dose-response relationship in multistage carcinogenesis: promoters. Environ Health Perspect. 1994 Jan;102 (Suppl 1):255–264. doi: 10.1289/ehp.94102s1255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Leverkus M., Neumann M., Mengling T., Rauch C. T., Bröcker E. B., Krammer P. H., Walczak H. Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytes. Cancer Res. 2000 Feb 1;60(3):553–559. [PubMed] [Google Scholar]
  19. Li J. J., Cao Y., Young M. R., Colburn N. H. Induced expression of dominant-negative c-jun downregulates NFkappaB and AP-1 target genes and suppresses tumor phenotype in human keratinocytes. Mol Carcinog. 2000 Nov;29(3):159–169. doi: 10.1002/1098-2744(200011)29:3<159::aid-mc5>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  20. Li J. J., Dong Z., Dawson M. I., Colburn N. H. Inhibition of tumor promoter-induced transformation by retinoids that transrepress AP-1 without transactivating retinoic acid response element. Cancer Res. 1996 Feb 1;56(3):483–489. [PubMed] [Google Scholar]
  21. Li J. J., Rhim J. S., Schlegel R., Vousden K. H., Colburn N. H. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes. Oncogene. 1998 May 28;16(21):2711–2721. doi: 10.1038/sj.onc.1201798. [DOI] [PubMed] [Google Scholar]
  22. Li J. J., Westergaard C., Ghosh P., Colburn N. H. Inhibitors of both nuclear factor-kappaB and activator protein-1 activation block the neoplastic transformation response. Cancer Res. 1997 Aug 15;57(16):3569–3576. [PubMed] [Google Scholar]
  23. Liu G., Bibus D. M., Bode A. M., Ma W. Y., Holman R. T., Dong Z. Omega 3 but not omega 6 fatty acids inhibit AP-1 activity and cell transformation in JB6 cells. Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7510–7515. doi: 10.1073/pnas.131195198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Liu G., Chen N., Kaji A., Bode A. M., Ryan C. A., Dong Z. Proteinase inhibitors I and II from potatoes block UVB-induced AP-1 activity by regulating the AP-1 protein compositional patterns in JB6 cells. Proc Natl Acad Sci U S A. 2001 May 1;98(10):5786–5791. doi: 10.1073/pnas.101116298. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Lu Y. P., Chang R. L., Lou Y. R., Huang M. T., Newmark H. L., Reuhl K. R., Conney A. H. Effect of curcumin on 12-O-tetradecanoylphorbol-13-acetate- and ultraviolet B light-induced expression of c-Jun and c-Fos in JB6 cells and in mouse epidermis. Carcinogenesis. 1994 Oct;15(10):2363–2370. doi: 10.1093/carcin/15.10.2363. [DOI] [PubMed] [Google Scholar]
  26. Lutz W. K., Beland P. E., Candrian R., Fekete T., Fischer W. H. Dose-time response in mouse skin tumor induction by 7, 12-dimethylbenz[a]anthracene and 12-O-tetradecanoyl-phorbol-13-acetate. Regul Toxicol Pharmacol. 1996 Feb;23(1 Pt 1):44–48. doi: 10.1006/rtph.1996.0007. [DOI] [PubMed] [Google Scholar]
  27. May M. J., Ghosh S. Rel/NF-kappa B and I kappa B proteins: an overview. Semin Cancer Biol. 1997 Apr;8(2):63–73. doi: 10.1006/scbi.1997.0057. [DOI] [PubMed] [Google Scholar]
  28. Moore R. J., Owens D. M., Stamp G., Arnott C., Burke F., East N., Holdsworth H., Turner L., Rollins B., Pasparakis M. Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis. Nat Med. 1999 Jul;5(7):828–831. doi: 10.1038/10552. [DOI] [PubMed] [Google Scholar]
  29. Nakamura S., Takahashi H., Kinouchi M., Manabe A., Ishida-Yamamoto A., Hashimoto Y., Iizuka H. Differential phosphorylation of mitogen-activated protein kinase families by epidermal growth factor and ultraviolet B irradiation in SV40-transformed human keratinocytes. J Dermatol Sci. 2001 Feb;25(2):139–149. doi: 10.1016/s0923-1811(00)00123-7. [DOI] [PubMed] [Google Scholar]
  30. Price M. A., Cruzalegui F. H., Treisman R. The p38 and ERK MAP kinase pathways cooperate to activate Ternary Complex Factors and c-fos transcription in response to UV light. EMBO J. 1996 Dec 2;15(23):6552–6563. [PMC free article] [PubMed] [Google Scholar]
  31. Ransone L. J., Verma I. M. Nuclear proto-oncogenes fos and jun. Annu Rev Cell Biol. 1990;6:539–557. doi: 10.1146/annurev.cb.06.110190.002543. [DOI] [PubMed] [Google Scholar]
  32. Saffer J. D., Chen G., Colburn N. H., Thurston S. J. Power frequency magnetic fields do not contribute to transformation of JB6 cells. Carcinogenesis. 1997 Jul;18(7):1365–1370. doi: 10.1093/carcin/18.7.1365. [DOI] [PubMed] [Google Scholar]
  33. Singh N., Sun Y., Nakamura K., Smith M. R., Colburn N. H. C-JUN/AP-1 as possible mediators of tumor necrosis factor-alpha-induced apoptotic response in mouse JB6 tumor cells. Oncol Res. 1995;7(7-8):353–362. [PubMed] [Google Scholar]
  34. Snawder J. E. Effect of magnetic field exposure on anchorage-independent growth of a promoter-sensitive mouse epidermal cell line (JB6). Environ Health Perspect. 1999 Mar;107(3):195–198. doi: 10.1289/ehp.99107195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Suganuma M., Okabe S., Marino M. W., Sakai A., Sueoka E., Fujiki H. Essential role of tumor necrosis factor alpha (TNF-alpha) in tumor promotion as revealed by TNF-alpha-deficient mice. Cancer Res. 1999 Sep 15;59(18):4516–4518. [PubMed] [Google Scholar]
  36. Takahashi K., Heine U. I., Junker J. L., Colburn N. H., Rice J. M. Role of cytoskeleton changes and expression of the H-ras oncogene during promotion of neoplastic transformation in mouse epidermal JB6 cells. Cancer Res. 1986 Nov;46(11):5923–5932. [PubMed] [Google Scholar]
  37. Watts R. G., Huang C., Young M. R., Li J. J., Dong Z., Pennie W. D., Colburn N. H. Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformation. Oncogene. 1998 Dec 31;17(26):3493–3498. doi: 10.1038/sj.onc.1202259. [DOI] [PubMed] [Google Scholar]
  38. Whitmarsh A. J., Shore P., Sharrocks A. D., Davis R. J. Integration of MAP kinase signal transduction pathways at the serum response element. Science. 1995 Jul 21;269(5222):403–407. doi: 10.1126/science.7618106. [DOI] [PubMed] [Google Scholar]
  39. Young M. R., Li J. J., Rincón M., Flavell R. A., Sathyanarayana B. K., Hunziker R., Colburn N. Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion. Proc Natl Acad Sci U S A. 1999 Aug 17;96(17):9827–9832. doi: 10.1073/pnas.96.17.9827. [DOI] [PMC free article] [PubMed] [Google Scholar]